Pacer Advisors, Inc. Care Dx, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.56 - $16.15 $8,988 - $19,202	-1,189 Reduced 70.02%	509 $7,000
Q1 2024 May 10, 2024	BUY	$7.96 - $12.37 $13,516 - $21,004	1,698 New	1,698 $17,000
Q2 2021 Jul 21, 2021	SELL	$63.02 - $95.11 $72,725 - $109,756	-1,154 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$57.62 - $95.6 $43,675 - $72,464	-758 Reduced 39.64%	1,154 $79,000
Q4 2020 Jan 20, 2021	SELL	$41.43 - $77.09 $24,112 - $44,866	-582 Reduced 23.34%	1,912 $139,000
Q3 2020 Oct 19, 2020	BUY	$30.88 - $37.94 $77,014 - $94,622	2,494 New	2,494 $95,000
Q4 2018 Feb 13, 2019	SELL	$19.89 - $30.02 $48,849 - $73,729	-2,456 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $29,717 - $70,855	2,456 New	2,456 $71,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.